1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : BIOTECH
  4. MERUS N.V
Merus N.V XNAS: MRUS

Merus N.V Live Stock Price Today, Share Analysis and Chart

Momentum Trap
about

Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing full-length human multispecific antibody therapeutics, referred to as Biclonics. Merus has only one reportable segment compr...

Read More
66.23 -0.39 (-0.59%)
Near 52W High of $69.20
425.3K
XNAS Volume

XNAS 04 Sep, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Alert

Share
Board Meeting
The latest board meeting for Merus N.V took place on 04 Sep 2025, for the purpose of Merus N.V. Wells Fargo Healthcare Conference 2025 See details
Durability score
Low Financial Strength
16.7 / 100
Valuation Score
Expensive Valuation
5.3 / 100
Momentum Score
Technically Moderately Bullish
62.1 / 100
Momentum Trap These stocks are with a bad quality and poor financial score ranging from medium to expensive valuation. Rising technical aspects may attract investors, but, weak financials cannot be overlooked. View Similar Embed DVM
Analyst Price Target
90
1Yr Price target upside is 36%
16 analysts

10

S

9

W

5

O

0

T

SWOT Analysis

Merus N.V Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..